Humatin
Active substance: paromomycin
CAPSULE · PAROMOMYCIN SULFATE 250 mg/1
United StatesActive
Marketing holder: Waylis Therapeutics LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- PAROMOMYCIN SULFATE · 250 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208d-cbe6-7743-9345-126eb2797426;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 80725-250
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 80725-250 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 80725-250 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 80725-250 · Verified 2026-10-09 · open in source